Corporate

Media

Sustainability

Award & Certification​

Leadership Team

Board of Directors

Who We Are

Pipeline

Technology

Publication Library

What We Do

Careers

People and Culture

News

Announcements

Events

What’s New

Company Profile

Corporate Governance

Stakeholder

Monthly Revenue

Annual Report

Financial Report

Stock Quote

IR Presentation

Investors

Contact

News & Events

People & Culture

OBI Information

DIFICID (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of CDAD

News - OBI Pharma 台灣浩鼎

Default Confirmation

If you need to contact us, please fill out the following form.

By submitting this form, you agree to our <a href="/privacy-policy" target="_blank">Privacy Policy</a>.

Enter consent agreement text here.  The Consent Field will store this agreement text with the form entry in order to track what the user has consented to.

Admin Notification

New submission from {form_title}

Contact Us - EN

Compliance